June 30, 2017

Forest Laboratories, LLC et al v. Sun Pharma Global FZE et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. January 16, 2018

    Allergan Deal Clears 2031 Launch Of Sun's Linzess Generic

    Sun Pharma will be able to sell its generic version of the constipation medication Linzess in February 2031 as part of a deal announced Tuesday to end patent infringement litigation being brought by the drug's makers, Allergan PLC and Ironwood Pharmaceuticals Inc.


Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS